ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party: original article
Introduction: Extracorporal Photophoresis (ECP) is in clinical use for steroid-refractory and steroid-dependent acute GVHD (SR-aGVHD). Based on recent Phase-III study results, ruxolitinib has become the new standard of care for SR-aGVHD. Our aim was to collect comparative data between ruxolitinib an...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
11 December 2023
|
| In: |
Frontiers in immunology
Year: 2023, Volume: 14, Pages: 1-9 |
| ISSN: | 1664-3224 |
| DOI: | 10.3389/fimmu.2023.1283034 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fimmu.2023.1283034 Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1283034/full 
|
| Author Notes: | Olaf Penack, Christophe Peczynski, William Boreland, Jessica Lemaitre, Ksenia Afanasyeva, Brian Kornblit, Manuel Jurado, Carmen Martinez, Annalisa Natale, Jose Antonio Pérez-Simón, Lucia Brunello, Daniele Avenoso, Stefan Klein, Zubeyde Nur Ozkurt, Concha Herrera, Stina Wichert, Patrizia Chiusolo, Eleni Gavriilaki, Grzegorz W. Basak, Hélène Schoemans, Christian Koenecke, Ivan Moiseev and Zinaida Peric |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 188595249X | ||
| 003 | DE-627 | ||
| 005 | 20240703165058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2023.1283034 |2 doi | |
| 035 | |a (DE-627)188595249X | ||
| 035 | |a (DE-599)KXP188595249X | ||
| 035 | |a (OCoLC)1443669073 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Penack, Olaf |d 1971- |e VerfasserIn |0 (DE-588)123860938 |0 (DE-627)706454561 |0 (DE-576)293914265 |4 aut | |
| 245 | 1 | 0 | |a ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party |b original article |c Olaf Penack, Christophe Peczynski, William Boreland, Jessica Lemaitre, Ksenia Afanasyeva, Brian Kornblit, Manuel Jurado, Carmen Martinez, Annalisa Natale, Jose Antonio Pérez-Simón, Lucia Brunello, Daniele Avenoso, Stefan Klein, Zubeyde Nur Ozkurt, Concha Herrera, Stina Wichert, Patrizia Chiusolo, Eleni Gavriilaki, Grzegorz W. Basak, Hélène Schoemans, Christian Koenecke, Ivan Moiseev and Zinaida Peric |
| 264 | 1 | |c 11 December 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.04.2024 | ||
| 520 | |a Introduction: Extracorporal Photophoresis (ECP) is in clinical use for steroid-refractory and steroid-dependent acute GVHD (SR-aGVHD). Based on recent Phase-III study results, ruxolitinib has become the new standard of care for SR-aGVHD. Our aim was to collect comparative data between ruxolitinib and ECP in SR-aGVHD in order to improve the evidence base for clinical decision making. Methods: We asked EBMT centers if they were willing to participate in this study by completing a data form (Med-C) with detailed information on GVHD grading, -therapy, -dosing, -response and complications for each included patient. Results: 31 centers responded positively (14%) and we included all patients receiving alloSCT between 1/2017-7/2019 and treated with ECP or ruxolitinib for SR-aGVHD grades II-IV from these centers. We identified 53 and 40 patients with grades II-IV SR-aGVHD who were treated with ECP and ruxolitinib, respectively. We performed multivariate analyses adjusted on grading and type of SR-aGVHD (steroid dependent vs. refractory). At day+90 after initiation of treatment for SR-aGVHD we found no statistically significant differences in overall response. The odds ratio in the ruxolitinib group to achieve overall response vs. the ECP group was 1.13 (95% CI = [0.41; 3.22], p = 0.81). In line, we detected no statistically significant differences in overall survival, progression-free survival, non-relapse mortality and relapse incidence. Discussion: The clinical significance is limited by the retrospective study design and the current data can’t replace prospective studies on ECP in SR-aGVHD. However, the present results contribute to the accumulating evidence on ECP as an effective treatment option in SR-aGVHD. | ||
| 650 | 4 | |a Allogeneic stem cell transplanation | |
| 650 | 4 | |a ECP | |
| 650 | 4 | |a GvHD | |
| 650 | 4 | |a ruxolinitib | |
| 650 | 4 | |a Steroid-refractory | |
| 700 | 1 | |a Peczynski, Christophe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Boreland, William |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lemaitre, Jessica |e VerfasserIn |4 aut | |
| 700 | 1 | |a Afanasyeva, Ksenia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kornblit, Brian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jurado, Manuel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martinez, Carmen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Natale, Annalisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pérez-Simón, Jose Antonio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brunello, Lucia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Avenoso, Daniele |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Stefan |e VerfasserIn |0 (DE-588)1042491836 |0 (DE-627)769066372 |0 (DE-576)393988791 |4 aut | |
| 700 | 1 | |a Ozkurt, Zubeyde Nur |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herrera, Concha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wichert, Stina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chiusolo, Patrizia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gavriilaki, Eleni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Basak, Grzegorz W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schoemans, Hélène |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koenecke, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moiseev, Ivan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Peric, Zinaida |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d Lausanne : Frontiers Media, 2010 |g 14(2023), Seite 1-9 |h Online-Ressource |w (DE-627)657998354 |w (DE-600)2606827-8 |w (DE-576)343624834 |x 1664-3224 |7 nnas |a ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party original article |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g pages:1-9 |g extent:9 |a ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party original article |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2023.1283034 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1283034/full |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240416 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1042491836 |a Klein, Stefan |m 1042491836:Klein, Stefan |d 60000 |e 60000PK1042491836 |k 0/60000/ |p 13 | ||
| 999 | |a KXP-PPN188595249X |e 4512565973 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party original articleFrontiers in immunology","note":["Gesehen am 07.11.13"],"language":["eng"],"title":[{"title":"Frontiers in immunology","title_sort":"Frontiers in immunology"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"657998354","origin":[{"publisher":"Frontiers Media","dateIssuedDisp":"2010-","publisherPlace":"Lausanne","dateIssuedKey":"2010"}],"pubHistory":["1.2010 -"],"part":{"extent":"9","year":"2023","volume":"14","text":"14(2023), Seite 1-9","pages":"1-9"},"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["657998354"],"issn":["1664-3224"],"zdb":["2606827-8"]}}],"title":[{"title_sort":"ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party","subtitle":"original article","title":"ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party"}],"id":{"doi":["10.3389/fimmu.2023.1283034"],"eki":["188595249X"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"noteIll":"Illustrationen","extent":"9 S."}],"language":["eng"],"person":[{"display":"Penack, Olaf","role":"aut","family":"Penack","given":"Olaf"},{"display":"Peczynski, Christophe","role":"aut","family":"Peczynski","given":"Christophe"},{"display":"Boreland, William","role":"aut","family":"Boreland","given":"William"},{"family":"Lemaitre","given":"Jessica","display":"Lemaitre, Jessica","role":"aut"},{"family":"Afanasyeva","given":"Ksenia","display":"Afanasyeva, Ksenia","role":"aut"},{"role":"aut","display":"Kornblit, Brian","given":"Brian","family":"Kornblit"},{"family":"Jurado","given":"Manuel","display":"Jurado, Manuel","role":"aut"},{"display":"Martinez, Carmen","role":"aut","family":"Martinez","given":"Carmen"},{"given":"Annalisa","family":"Natale","role":"aut","display":"Natale, Annalisa"},{"family":"Pérez-Simón","given":"Jose Antonio","display":"Pérez-Simón, Jose Antonio","role":"aut"},{"role":"aut","display":"Brunello, Lucia","given":"Lucia","family":"Brunello"},{"role":"aut","display":"Avenoso, Daniele","given":"Daniele","family":"Avenoso"},{"role":"aut","display":"Klein, Stefan","given":"Stefan","family":"Klein"},{"display":"Ozkurt, Zubeyde Nur","role":"aut","family":"Ozkurt","given":"Zubeyde Nur"},{"role":"aut","display":"Herrera, Concha","given":"Concha","family":"Herrera"},{"role":"aut","display":"Wichert, Stina","given":"Stina","family":"Wichert"},{"given":"Patrizia","family":"Chiusolo","role":"aut","display":"Chiusolo, Patrizia"},{"family":"Gavriilaki","given":"Eleni","display":"Gavriilaki, Eleni","role":"aut"},{"given":"Grzegorz W.","family":"Basak","role":"aut","display":"Basak, Grzegorz W."},{"display":"Schoemans, Hélène","role":"aut","family":"Schoemans","given":"Hélène"},{"family":"Koenecke","given":"Christian","display":"Koenecke, Christian","role":"aut"},{"role":"aut","display":"Moiseev, Ivan","given":"Ivan","family":"Moiseev"},{"role":"aut","display":"Peric, Zinaida","given":"Zinaida","family":"Peric"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"11 December 2023"}],"note":["Gesehen am 16.04.2024"],"recId":"188595249X","name":{"displayForm":["Olaf Penack, Christophe Peczynski, William Boreland, Jessica Lemaitre, Ksenia Afanasyeva, Brian Kornblit, Manuel Jurado, Carmen Martinez, Annalisa Natale, Jose Antonio Pérez-Simón, Lucia Brunello, Daniele Avenoso, Stefan Klein, Zubeyde Nur Ozkurt, Concha Herrera, Stina Wichert, Patrizia Chiusolo, Eleni Gavriilaki, Grzegorz W. Basak, Hélène Schoemans, Christian Koenecke, Ivan Moiseev and Zinaida Peric"]}} | ||
| SRT | |a PENACKOLAFECPVERSUSR1120 | ||